Agencia Estatal de Investigación
2024-10-03
Despite advances in Ir(III) and Ru(II) photosensitizers (PSs), their lack of selectivity for cancer cells has hindered their use in photodynamic therapy (PDT). We disclose the synthesis and characterization of two pairs of Ir(III) and Ru(II) polypyridyl complexes bearing two β-carboline ligands (N^N’) functionalized with −COOMe (L1) or −COOH (L2), resulting in PSs of formulas [Ir(C^N)2(N^N’)]Cl (Ir-Me: C^N = ppy, N^N’ = L1; Ir-H: C^N = ppy, N^N’ = L2) and [Ru(N^N)2(N^N’)](Cl)2 (Ru-Me: N^N = bpy, N^N’ = L1; Ru-H: N^N = bpy, N^N’ = L2). To enhance their selectivity toward cancer cells, Ir-H and Ru-H were coupled to a bombesin derivative (BN3), resulting in the metallopeptides Ir-BN and Ru-BN. Ir(III) complexes showed higher anticancer activity than their Ru(II) counterparts, particularly upon blue light irradiation, but lacked cancer cell selectivity. In contrast, Ir-BN and Ru-BN exhibited selective photocytoxicity against prostate cancer cells, with a lower effect against nonmalignant fibroblasts. All compounds generated ROS and induced severe mitochondrial toxicity upon photoactivation, leading to apoptosis. Additionally, the ability of Ir-Me to oxidize NADH was demonstrated, suggesting a mechanism for mitochondrial damage. Our findings indicated that the conjugation of metal PSs with BN3 creates efficient PDT agents, achieving selectivity through targeting bombesin receptors and local photoactivation
This work was supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (MCIN/AEI) of Spain (projects PID2021-127187OB-C21 and PID2021-127187OB-C22/MCIN/AEI/10.13039/501100011033/FEDER, UE). PhD students acknowledge their predoctoral grants to Universidad de Burgos (J.S.V., 2019/00002/008/001) and University of Girona (C.B., IFUdG2021; G.R., IFUdG2020). Open Access funding provided thanks to the CRUE-CSIC agreement with American Chemical Society (ACS)
Article
Published version
peer-reviewed
English
Pròstata -- Càncer -- Tractament; Prostate -- Cancer -- Treatment; Fotoquimioteràpia; Photochemotherapy
American Chemical Society (ACS)
info:eu-repo/semantics/altIdentifier/doi/10.1021/acs.inorgchem.4c02583
info:eu-repo/semantics/altIdentifier/issn/0020-1669
info:eu-repo/semantics/altIdentifier/eissn/1520-510X
PID2021-127187OB-C22
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-127187OB-C22/ES/ESTRATEGIAS AVANZADAS EN EL DISEÑO DE FOTOSENSIBILIZADORES BASADOS EN METALES PARA EL TRATAMIENTO DEL CANCER. HACIA UNA TERAPIA FOTODINAMICA DIRIGIDA, MAS PRECISA Y EFICAZ/
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/